We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

53 hedge funds and large institutions have $19.7M invested in Vaxart in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5353 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

22% less capital invested

Capital invested by funds: $25.4M → $19.7M (-$5.71M)

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
53
Holders Change
Holders Change %
0%
% of All Funds
1.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
11
Reduced
16
Closed
5
Calls
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
51
Citigroup
New York
+$250 +14 New

VXRT Hedge Fund Activity: Q1 2016 in Review

53 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2016, worth a combined $19.7M — down 22% from $25.4M a quarter earlier.

Fund positioning in VXRT was balanced in Q1 2016: 5 funds opened new positions, 5 closed out, 11 added to existing stakes and 16 trimmed.

The largest buyer was Vanguard Group, adding an estimated $725K. The largest seller was Fidelity Investments, cutting an estimated $571K.

  • 53 institutional investors held Vaxart (VXRT) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $19.7M of Vaxart stock for Q1 2016, down 22% quarter-over-quarter.
  • 5 funds opened new Vaxart positions in Q1 2016 and 5 closed out, a net change of 0 holders.
  • The largest Vaxart buyer in Q1 2016 was Vanguard Group, an estimated $725K added.
  • The largest Vaxart seller in Q1 2016 was Fidelity Investments, an estimated $571K sold.

Based on aggregated 13F filings for Q1 2016.